Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world
Matthieu Million, Philippe Gautret, Philippe Colson, et al.
New Microbes and New Infections (2020) Vol. 38, pp. 100709-100709
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Jean‐Christophe Lagier, Matthieu Million, Philippe Gautret, et al.
Travel Medicine and Infectious Disease (2020) Vol. 36, pp. 101791-101791
Open Access | Times Cited: 254
Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 143
Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations
Jun Wu, Jian Wang, Stephen Nicholas, et al.
Journal of Medical Internet Research (2020) Vol. 22, Iss. 10, pp. e21980-e21980
Open Access | Times Cited: 139
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
Arunmozhimaran Elavarasi, Manya Prasad, Tulika Seth, et al.
Journal of General Internal Medicine (2020) Vol. 35, Iss. 11, pp. 3308-3314
Open Access | Times Cited: 108
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Roland Derwand, Martin Scholz, Vladimir Zelenko
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 6, pp. 106214-106214
Open Access | Times Cited: 102
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes
Andrea De Vito, Vito Fiore, Elija Princic, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248009-e0248009
Open Access | Times Cited: 63
Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture
Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 37
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 45
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Wei‐Yi Ong, Mei‐Lin Go, De Yun Wang, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 106-117
Open Access | Times Cited: 45
Big Data COVID-19 Systematic Literature Review: Pandemic Crisis
Laraib Aslam Haafza, Mazhar Javed Awan, Adnan Abid, et al.
Electronics (2021) Vol. 10, Iss. 24, pp. 3125-3125
Open Access | Times Cited: 33
Drug safety of frequently used drugs and substances for self-medication in COVID-19
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 23
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
Luis Ayerbe, Carlos Risco-Risco, Salma Ayis
Internal and Emergency Medicine (2020) Vol. 15, Iss. 8, pp. 1501-1506
Open Access | Times Cited: 36
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
Guillaume Hache, Jean‐Marc Rolain, Philippe Gautret, et al.
Microbial Drug Resistance (2021) Vol. 27, Iss. 3, pp. 281-290
Open Access | Times Cited: 29
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Isabella Romeo, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 632-632
Open Access | Times Cited: 28
Moments in autophagy and disease: Past and present
Xin Wen, Ying Yang, Daniel J. Klionsky
Molecular Aspects of Medicine (2021) Vol. 82, pp. 100966-100966
Open Access | Times Cited: 28
Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection
Subhajit Maity, Abhik Saha
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 28
Efficacy of Chloroquine and Hydroxychloroquine for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, et al.
Future Virology (2021) Vol. 17, Iss. 2, pp. 95-118
Open Access | Times Cited: 24
Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
Paul Eze, Kenechukwu Mezue, Chidozie Nduka, et al.
PubMed (2021) Vol. 11, Iss. 1, pp. 93-107
Closed Access | Times Cited: 23
Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies—need for data validation of the completed trials and to improve ongoing and future randomised trial designs
Venkata R. Emani, Sanjeev Goswami, Dheeraj Nandanoor, et al.
International Journal of Antimicrobial Agents (2020) Vol. 57, Iss. 1, pp. 106222-106222
Open Access | Times Cited: 24
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 138-140
Open Access | Times Cited: 20
Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective
Yashwant Kumar Ratre, Namrata Kahar, L.V.K.S. Bhaskar, et al.
3 Biotech (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 17
Big data driven COVID-19 pandemic crisis management: Potential approach for global health
Yang Lv, Chenwei Ma, Xiaohan Li, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 3, pp. 829-837
Open Access | Times Cited: 17
Big Data Research in Fighting COVID-19: Contributions and Techniques
Dianadewi Riswantini, Ekasari Nugraheni, Andria Arisal, et al.
Big Data and Cognitive Computing (2021) Vol. 5, Iss. 3, pp. 30-30
Open Access | Times Cited: 17
Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseases
Clara Locher, David Moher, Ioana A. Cristea, et al.
BMJ evidence-based medicine (2021) Vol. 27, Iss. 3, pp. 133-136
Open Access | Times Cited: 16
Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry
Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top